Skip to content

Select language:

1800 620 420

Blood cancer information
How we can help
Get involved

Donate Menu Search

Home
Online Blood Cancer Support Service
Blood cancer information
How we can help
Research
Advocacy & policy
Get involved
Make a donation
About us
News
Contact us
- Office locations and contact details

Search

Category: Blood Cancer Information

Optimal Care Pathways for myelodysplastic syndromes (MDS) patients

Myelodysplastic syndromes
Myeloproliferative neoplasms

Read more

Optimal Care Pathways for myeloma patients

Myeloma

Read more

Optimal Care Pathways for lymphoma patients

Hodgkin lymphoma
Non-Hodgkin lymphoma

Read more

Optimal Care Pathways for leukaemia patients

Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Chronic lymphocytic leukaemia
Chronic myeloid leukaemia

Read more

Optimal Care Pathways for myelodysplastic syndromes (MDS) – HCP

Myelodysplastic syndromes
Myeloproliferative neoplasms

Read more

Optimal Care Pathways for myeloma – HCP

Myeloma

Read more

Optimal Care Pathways for lymphoma – HCP

Hodgkin lymphoma
Non-Hodgkin lymphoma

Read more

Optimal Care Pathways for leukaemia – HCP

Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Chronic lymphocytic leukaemia
Chronic myeloid leukaemia

Read more

Blood cancer related fatigue

Read more

Immunotherapies and Targeted therapies

Read more

Posts navigation

Search for:

Recent Posts

The Leukaemia Foundation welcomes Australian Government decision to ban using adverse genetic testing results in life insurance
World Marrow Donor Day 2024
‘Made me the person I am today’
Talking Blood Cancer: Regional Resilience
From nurse to patient

Blood cancer A – Z

Acute lymphoblastic leukaemia (ALL)
Acute myeloid leukemia (AML)
Acute promyelocytic leukaemia (APML)
Adult T-cell lymphoma (ATLL)
Anaplastic large cell lymphoma (ALCL)
Amyloidosis
Aplastic anaemia (AA)
Biphenotypic leukaemia
Burkitt’s lymphoma
Chronic lymphocytic leukaemia (CLL)
Chronic myeloid leukaemia (CML)
CNS lymphoma
Diffuse large B-cell lymphoma (DLBCL)
Double hit lymphoma (DHL)
Essential Thrombocythaemia (ET)
Follicular lymphoma (FL)
Hairy cell leukaemia (HCL)
Hodgkin lymphoma (HL)
Leukaemia / Leukemia
Lymphoblastic lymphoma (LL)
Lymphoma
MALT lymphoma
Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL)
Monoclonal gammopathy of unknown significance (MGUS)
Myelodysplastic neoplasms (MDS)
Myelofibrosis (MF)
Myeloma
Myeloproliferative neoplasms (MPN)
Non-Hodgkin lymphoma (NHL)
Peripheral T-cell lymphoma (PTCL)
Polycythaemia (Rubra) vera (PRV)
Skin lymphomas
Small lymphocytic lymphoma (SLL)
Solitary plasmacytoma
Waldenstrom’s macroglobulinaemia (WM)

The Leukaemia Foundation acknowledges the traditional owners of country throughout Australia and recognises their continuing connection to land, sea and community. We pay our respects to their Elders past, present and emerging.

The Leukaemia Foundation is committed to ensuring that everyone is treated with dignity regardless of their ability, cultural background, religion, ethnicity, gender identity, intersex status or sexual orientation.

Need to talk?

Speak with our Blood Cancer Support Coordinators via our Online Blood Cancer Support Service or via 1800 620 420

Sign up for news

Keep up to date with what's happening in the world of blood cancer.

Subscribe today

Join our Facebook groups

Express concerns, ask questions and share information on living with blood cancer.

Join our networks

Connect with us

© 2024 Leukaemia Foundation

Privacy
Disclaimer
Site map
Contact us